Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent

X Wang, Y Feng, T Ke, M Schabel, ZR Lu - Pharmaceutical research, 2005 - Springer
No Heading Purpose. To investigate the pharmacokinetics, long-term tissue retention of Gd
(III) ions, and magnetic resonance imaging (MRI) contrast enhancement of extracellular …

Stability and biodistribution of a biodegradable macromolecular MRI contrast agent Gd-DTPA cystamine copolymers (GDCC) in rats

X Wu, Y Zong, Z Ye, ZR Lu - Pharmaceutical research, 2010 - Springer
Purpose The aim of this study was to evaluate stability and Gd tissue distribution of a
biodegradable macromolecular MRI contrast agent, GDCC. Methods Kinetic stability of …

Gd-DTPA l-Cystine Bisamide Copolymers as Novel Biodegradable Macromolecular Contrast Agents for MR Blood Pool Imaging

TL Kaneshiro, T Ke, EK Jeong, DL Parker… - Pharmaceutical …, 2006 - Springer
Purpose The purpose of this study was to synthesize biodegradable Gd-DTPA l-cystine
bisamide copolymers (GCAC) as safe and effective, macromolecular contrast agents for …

Modification of Gd‐DTPA cystine copolymers with PEG‐1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography

AM Mohs, T Nguyen, EK Jeong, Y Feng… - … in Medicine: An …, 2007 - Wiley Online Library
The purpose of this study was to investigate the effect of PEGylation of novel biodegradable
macromolecular polydisulfide Gd (III) complexes, gadolinium …

Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a …

Y Feng, Y Zong, T Ke, EK Jeong, DL Parker… - Pharmaceutical …, 2006 - Springer
Purpose To investigate plasma pharmacokinetics and biodistribution of biodegradable
polydisulfide Gd (III) complexes, Gd-DTPA cystine copolymers (GDCP) and Gd-DTPA …

In Vivo Evaluation of a PAMAM-Cystamine-(Gd-DO3A) Conjugate as a Biodegradable Macromolecular MRI Contrast Agent

R Xu, Y Wang, X Wang, EK Jeong… - Experimental …, 2007 - journals.sagepub.com
Macromolecular Gd (III) chelates are superior magnetic resonance imaging (MRI) contrast
agents for blood pool and tumor imaging. However, their clinical development is limited by …

The degradation and clearance of Poly (N-hydroxypropyl-L-glutamine)-DTPA-Gd as a blood pool MRI contrast agent

G Zhang, R Zhang, MP Melancon, K Wong, J You… - Biomaterials, 2012 - Elsevier
Although polymeric magnetic resonance imaging (MRI) agents have significantly improved
relaxivity and prolonged circulation time in vivo compared with current imaging agents, the …

Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood‐pool contrast agent PG–Gd in non‐human primates: a pilot study

M Tian, X Wen, EF Jackson, C Ng… - Contrast media & …, 2011 - Wiley Online Library
The purpose of this study was to evaluate poly (l‐glutamic acid)‐benzyl‐DTPA–Gd (PG–Gd),
a new biodegradable macromolecular magnetic resonance imaging contrast agent, for its …

Contrast‐enhanced MRI with new biodegradable macromolecular Gd (III) complexes in tumor‐bearing mice

Y Zong, X Wang, KC Goodrich, AM Mohs… - … in Medicine: An …, 2005 - Wiley Online Library
The structures of polydisulfide‐based biodegradable macromolecular Gd (III) complexes
were modified to improve their in vivo retention time and MRI contrast enhancement. Steric …

PEG-g-poly(GdDTPA-co-l-cystine):  Effect of PEG Chain Length on in Vivo Contrast Enhancement in MRI

AM Mohs, Y Zong, J Guo, DL Parker, ZR Lu - Biomacromolecules, 2005 - ACS Publications
Biodegradable macromolecular Gd (III) complexes, Gd-DTPA cystine copolymers (GDCP),
were grafted with PEG of different sizes to modify the physicochemical properties and in vivo …